Halt Medical has obtained $15m finance from American Capital to support the commercialization of its Acessa system, designed for treating uterine fibroids. Using a slender Handpiece, the CE-marked system delivers radiofrequency energy to ...
Tags: Halt Medical, American Capital, commercialization, Acessa system
The US Food and Drug Administration (FDA) has cleared Halt Medical's minimally invasive technology, designed for treating uterine fibroids. The Acessa technology, which is designed for preserving the normal function of the uterus, ...